Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess

Objective. Osteoporosis and osteopenia (OS/OP) are frequent in patients with adrenal adenomas associated with cortisol excess (CE). However, the relationship between OS/OP and CE severity considering sex differences is unknown. Design. A cross-sectional observational study from January 2006 to Decem...

Full description

Saved in:
Bibliographic Details
Main Authors: Shoichiro Izawa, Kazuhisa Matsumoto, Kazuhiko Matsuzawa, Takuyuki Katabami, Takanobu Yoshimoto, Michio Otsuki, Masakatsu Sone, Yoshiyu Takeda, Shintaro Okamura, Takamasa Ichijo, Mika Tsuiki, Tomoko Suzuki, Mitsuhide Naruse, Akiyo Tanabe
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2022/5009395
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564889406668800
author Shoichiro Izawa
Kazuhisa Matsumoto
Kazuhiko Matsuzawa
Takuyuki Katabami
Takanobu Yoshimoto
Michio Otsuki
Masakatsu Sone
Yoshiyu Takeda
Shintaro Okamura
Takamasa Ichijo
Mika Tsuiki
Tomoko Suzuki
Mitsuhide Naruse
Akiyo Tanabe
author_facet Shoichiro Izawa
Kazuhisa Matsumoto
Kazuhiko Matsuzawa
Takuyuki Katabami
Takanobu Yoshimoto
Michio Otsuki
Masakatsu Sone
Yoshiyu Takeda
Shintaro Okamura
Takamasa Ichijo
Mika Tsuiki
Tomoko Suzuki
Mitsuhide Naruse
Akiyo Tanabe
author_sort Shoichiro Izawa
collection DOAJ
description Objective. Osteoporosis and osteopenia (OS/OP) are frequent in patients with adrenal adenomas associated with cortisol excess (CE). However, the relationship between OS/OP and CE severity considering sex differences is unknown. Design. A cross-sectional observational study from January 2006 to December 2015. Patients. 237 patients with adrenal adenoma associated with CE, including Cushing’s syndrome and mild autonomous cortisol secretion (MACS), diagnosed in 10 referral centers in Japan. MACS was defined by 1 mg overnight dexamethasone suppression test (DST) cortisol level >1.8 μg/dL. Measurements. Prevalence of fragility fractures, medication for osteoporosis, and bone mineral density. Results. In total, 112 of 237 patients, who were predominantly female (P<0.001) and had lower BMI (P=0.013), had OS/OP. Patients with OS/OP was significantly affected by CE (P<0.01) than those without. The adjusted odds ratio (OR) for predicting OS/OP was obtained in multivariate logistic regression analysis. Clinical measures of CE, 1 mg DST cortisol levels, were positively associated with OS/OP in total cases (OR 1.124, 95% CI: 1.070–1.181, P<0.001) and the cases with MACS (OR 1.156, 95%CI: 1.046–1.278, P=0.005). A cutoff value of 1 mg DST cortisol level >5.0 μg/dL was associated with OS/OP differently between men and women. OS/OP risk in men with MACS was significantly affected only by 1 mg DST cortisol levels. However, OS/OP risk in women with MACS was significantly affected by 1 mg DST cortisol levels and age. Conclusions. CE severity in adrenal adenoma is positively associated with OS/OP. However, the associated factors of OS/OP in the patients with MACS are different between men and women.
format Article
id doaj-art-604db6372abe4048a70ea52f8095da62
institution Kabale University
issn 1687-8345
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-604db6372abe4048a70ea52f8095da622025-02-03T01:09:54ZengWileyInternational Journal of Endocrinology1687-83452022-01-01202210.1155/2022/5009395Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol ExcessShoichiro Izawa0Kazuhisa Matsumoto1Kazuhiko Matsuzawa2Takuyuki Katabami3Takanobu Yoshimoto4Michio Otsuki5Masakatsu Sone6Yoshiyu Takeda7Shintaro Okamura8Takamasa Ichijo9Mika Tsuiki10Tomoko Suzuki11Mitsuhide Naruse12Akiyo Tanabe13Division of Endocrinology and MetabolismDivision of Endocrinology and MetabolismDivision of Endocrinology and MetabolismDivision of Metabolism and EndocrinologyDepartment of Molecular Endocrinology and MetabolismDepartment of Metabolic MedicineDepartment of Diabetes, Endocrinology and NutritionDepartment of Internal MedicineDepartment of EndocrinologyDepartment of Diabetes and EndocrinologyDepartment of Endocrinology and MetabolismDepartment of Public HealthClinical Research Institute of Endocrinology and MetabolismDivision of EndocrinologyObjective. Osteoporosis and osteopenia (OS/OP) are frequent in patients with adrenal adenomas associated with cortisol excess (CE). However, the relationship between OS/OP and CE severity considering sex differences is unknown. Design. A cross-sectional observational study from January 2006 to December 2015. Patients. 237 patients with adrenal adenoma associated with CE, including Cushing’s syndrome and mild autonomous cortisol secretion (MACS), diagnosed in 10 referral centers in Japan. MACS was defined by 1 mg overnight dexamethasone suppression test (DST) cortisol level >1.8 μg/dL. Measurements. Prevalence of fragility fractures, medication for osteoporosis, and bone mineral density. Results. In total, 112 of 237 patients, who were predominantly female (P<0.001) and had lower BMI (P=0.013), had OS/OP. Patients with OS/OP was significantly affected by CE (P<0.01) than those without. The adjusted odds ratio (OR) for predicting OS/OP was obtained in multivariate logistic regression analysis. Clinical measures of CE, 1 mg DST cortisol levels, were positively associated with OS/OP in total cases (OR 1.124, 95% CI: 1.070–1.181, P<0.001) and the cases with MACS (OR 1.156, 95%CI: 1.046–1.278, P=0.005). A cutoff value of 1 mg DST cortisol level >5.0 μg/dL was associated with OS/OP differently between men and women. OS/OP risk in men with MACS was significantly affected only by 1 mg DST cortisol levels. However, OS/OP risk in women with MACS was significantly affected by 1 mg DST cortisol levels and age. Conclusions. CE severity in adrenal adenoma is positively associated with OS/OP. However, the associated factors of OS/OP in the patients with MACS are different between men and women.http://dx.doi.org/10.1155/2022/5009395
spellingShingle Shoichiro Izawa
Kazuhisa Matsumoto
Kazuhiko Matsuzawa
Takuyuki Katabami
Takanobu Yoshimoto
Michio Otsuki
Masakatsu Sone
Yoshiyu Takeda
Shintaro Okamura
Takamasa Ichijo
Mika Tsuiki
Tomoko Suzuki
Mitsuhide Naruse
Akiyo Tanabe
Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess
International Journal of Endocrinology
title Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess
title_full Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess
title_fullStr Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess
title_full_unstemmed Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess
title_short Sex Difference in the Association of Osteoporosis and Osteopenia Prevalence in Patients with Adrenal Adenoma and Different Degrees of Cortisol Excess
title_sort sex difference in the association of osteoporosis and osteopenia prevalence in patients with adrenal adenoma and different degrees of cortisol excess
url http://dx.doi.org/10.1155/2022/5009395
work_keys_str_mv AT shoichiroizawa sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT kazuhisamatsumoto sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT kazuhikomatsuzawa sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT takuyukikatabami sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT takanobuyoshimoto sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT michiootsuki sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT masakatsusone sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT yoshiyutakeda sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT shintarookamura sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT takamasaichijo sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT mikatsuiki sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT tomokosuzuki sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT mitsuhidenaruse sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess
AT akiyotanabe sexdifferenceintheassociationofosteoporosisandosteopeniaprevalenceinpatientswithadrenaladenomaanddifferentdegreesofcortisolexcess